… to reduce their inappropriate consumption in the medium term. … application of a patient-centered
deprescription process in patients admitted to a gastroenterology department is feasible, …

… network of seven NCQA tier-3 patientcentered medical homes (PCMH) associated with an
… -led population health management process to deprescribe the inappropriate use of PPIs in …

… reduce harms associated with inappropriate medication use. … : 1) proton pump inhibitor
(PPI), de ned as use of any dose for … We conducted a pre-post feasibility trial of a patient-centered …

… use in this study (40%) is consistent with previous studies 6 and confirms that inappropriate
chronic PPI use … an additional 9% reduced their PPI dose or frequency of use. Only 1 patient …

… inappropriate dose (20/31). The following recommendations were made: PPI stopped in 5
patients, PPI dose reduced … Our pilot intervention was feasible and reduced week-to-week PPI …

… 1) chronic proton pump inhibitor users (PPI), defined as use of … We conducted a pre-post pilot
study of a patient-centered … explicate the effectiveness and feasibility of targeted mailings of …

… more successful than others in effectively deprescribing inappropriate PPIs in older adults.
However, whether PPI deprescribing translates into better clinical outcomes remains unclear. …

… who are inappropriately taking PPIs and deprescribe safely. … the feasibility of a patient-centered
PPI deprescribing process … The deprescribing process consisted of five steps including: …

… overuse of proton pump inhibitors in a safe, effective, and feasible manner in the nursing …
a systematic patient-centered as well as protocol-guided approach to reducing inappropriate …

… inappropriate use of PPI significantly decreased after implementation of a deprescribing
algorithm from 83.7% to 44.2% in the cohort of patients who were eligible for deprescribing (…